Business model
Miraculins is a research and development company focused on discovering, validating and developing biomarkers with clinical relevance for the diagnosis and treatment of cancer. The objective of Miraculins' business strategy is to create the best possible value for its shareholders by establishing partnerships for the optimal development and execution of its products.
Partnering
Miraculins is actively seeking partners to manufacture and commercialize its pipeline of products.
In-licensing
Miraculins has an interest in in-licensing technologies that complement its focus and build on its expertise in the areas of proteomics, biomarker discovery and the development of diagnostics and therapeutics to treat cancers.
